Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890428002> ?p ?o ?g. }
- W2890428002 endingPage "64" @default.
- W2890428002 startingPage "57" @default.
- W2890428002 abstract "Androgen deprivation therapy (ADT) has been the standard of care for the last 75 years in metastatic hormone sensitive prostate cancer (PCa). However, this approach is rarely curative. Recent clinical trials have demonstrated that ADT combined with other agents, notably docetaxel and abiraterone, lead to improved survival. The mechanisms surrounding this improved cancer outcomes are incompletely defined. The response of cancer cells to ADT includes apoptosis and cell death, but a significant fraction remains viable. Our laboratory has demonstrated both in vitro and in vivo that cellular senescence occurs in a subset of these cells. Cellular senescence is a phenotype characterized by cell cycle arrest, senescence-associated β-galactosidase (SA-β-gal), and a hypermetabolic state. Positive features of cellular senescence include growth arrest and immune stimulation, although persistence may release cytokines and growth factors that are detrimental. Senescent tumor cells generate a catabolic state with increased glycolysis, protein turnover and other metabolic changes that represent targets for drugs, like metformin, to be applied in a synthetic lethal approach. This review examines the response to ADT and the putative role of cellular senescence as a biomarker and therapeutic target in this context." @default.
- W2890428002 created "2018-09-27" @default.
- W2890428002 creator A5016291949 @default.
- W2890428002 creator A5030837242 @default.
- W2890428002 creator A5033987994 @default.
- W2890428002 creator A5046482805 @default.
- W2890428002 creator A5068154831 @default.
- W2890428002 creator A5073338534 @default.
- W2890428002 creator A5085135836 @default.
- W2890428002 creator A5085748768 @default.
- W2890428002 date "2019-01-01" @default.
- W2890428002 modified "2023-09-24" @default.
- W2890428002 title "Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier" @default.
- W2890428002 cites W1211637162 @default.
- W2890428002 cites W1523693806 @default.
- W2890428002 cites W1590842919 @default.
- W2890428002 cites W1971278726 @default.
- W2890428002 cites W1973328141 @default.
- W2890428002 cites W1976358806 @default.
- W2890428002 cites W1978120498 @default.
- W2890428002 cites W1981975569 @default.
- W2890428002 cites W1984557825 @default.
- W2890428002 cites W1987142903 @default.
- W2890428002 cites W1994474279 @default.
- W2890428002 cites W1995142571 @default.
- W2890428002 cites W2001209876 @default.
- W2890428002 cites W2002686926 @default.
- W2890428002 cites W2004314923 @default.
- W2890428002 cites W2018049857 @default.
- W2890428002 cites W2033746173 @default.
- W2890428002 cites W2034017362 @default.
- W2890428002 cites W2040620678 @default.
- W2890428002 cites W2041156660 @default.
- W2890428002 cites W2049293556 @default.
- W2890428002 cites W2051631814 @default.
- W2890428002 cites W2062400207 @default.
- W2890428002 cites W2064656431 @default.
- W2890428002 cites W2071942085 @default.
- W2890428002 cites W2075004958 @default.
- W2890428002 cites W2078893058 @default.
- W2890428002 cites W2086333179 @default.
- W2890428002 cites W2093397186 @default.
- W2890428002 cites W2095224133 @default.
- W2890428002 cites W2096989096 @default.
- W2890428002 cites W2100965400 @default.
- W2890428002 cites W2101399403 @default.
- W2890428002 cites W2104908670 @default.
- W2890428002 cites W2107019791 @default.
- W2890428002 cites W2117275311 @default.
- W2890428002 cites W2124033164 @default.
- W2890428002 cites W2131793954 @default.
- W2890428002 cites W2133021077 @default.
- W2890428002 cites W2134907909 @default.
- W2890428002 cites W2136380412 @default.
- W2890428002 cites W2142466432 @default.
- W2890428002 cites W2145898752 @default.
- W2890428002 cites W2147166694 @default.
- W2890428002 cites W2148180201 @default.
- W2890428002 cites W2150865892 @default.
- W2890428002 cites W2153382986 @default.
- W2890428002 cites W2157360354 @default.
- W2890428002 cites W2157402072 @default.
- W2890428002 cites W2157980218 @default.
- W2890428002 cites W2166732620 @default.
- W2890428002 cites W2170544517 @default.
- W2890428002 cites W2171998898 @default.
- W2890428002 cites W2180958531 @default.
- W2890428002 cites W2214621962 @default.
- W2890428002 cites W2321355800 @default.
- W2890428002 cites W2403350024 @default.
- W2890428002 cites W2555204225 @default.
- W2890428002 cites W2565768160 @default.
- W2890428002 cites W2570618306 @default.
- W2890428002 cites W2589995858 @default.
- W2890428002 cites W2620746860 @default.
- W2890428002 cites W2620798309 @default.
- W2890428002 cites W2768924090 @default.
- W2890428002 cites W2777786283 @default.
- W2890428002 cites W2791908555 @default.
- W2890428002 cites W2809237761 @default.
- W2890428002 cites W299669910 @default.
- W2890428002 doi "https://doi.org/10.1016/j.ajur.2018.09.001" @default.
- W2890428002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6363606" @default.
- W2890428002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30775249" @default.
- W2890428002 hasPublicationYear "2019" @default.
- W2890428002 type Work @default.
- W2890428002 sameAs 2890428002 @default.
- W2890428002 citedByCount "15" @default.
- W2890428002 countsByYear W28904280022019 @default.
- W2890428002 countsByYear W28904280022020 @default.
- W2890428002 countsByYear W28904280022021 @default.
- W2890428002 countsByYear W28904280022022 @default.
- W2890428002 countsByYear W28904280022023 @default.
- W2890428002 crossrefType "journal-article" @default.
- W2890428002 hasAuthorship W2890428002A5016291949 @default.
- W2890428002 hasAuthorship W2890428002A5030837242 @default.
- W2890428002 hasAuthorship W2890428002A5033987994 @default.
- W2890428002 hasAuthorship W2890428002A5046482805 @default.